After Wegovy and Zepbound, 6 weight-loss drugs in development
New weight-loss drugs from Novo Nordisk, Eli Lilly, Pfizer, Roche, Amgen and Viking Therapeutics offer a look at where obesity treatment could go after Wegovy and Zepbound
We haven't written up this one. Quartz has the full story — the link below goes straight to it.